This is not the most recent version of the article. View current version (17 SEP 2014)

Intervention Review

Antigen-specific active immunotherapy for ovarian cancer

  1. Ninke Leffers1,*,
  2. Toos Daemen2,
  3. Wijnand Helfrich2,
  4. H Marike Boezen3,
  5. Ben J Cohlen4,
  6. Kees Melief5,
  7. Hans W Nijman2

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 30 OCT 2009

DOI: 10.1002/14651858.CD007287.pub2


How to Cite

Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief K, Nijman HW. Antigen-specific active immunotherapy for ovarian cancer. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007287. DOI: 10.1002/14651858.CD007287.pub2.

Author Information

  1. 1

    University Medical Center Groningen, Obstetrics & Gynecology CB30, Groningen, Netherlands

  2. 2

    University Medical Center Groningen, Groningen, Netherlands

  3. 3

    University Medical Center Groningen, Unit Chronic Airway Diseases, Department of Epidemiology, Groningen, Netherlands

  4. 4

    Isala Clinics, Location Sophia, Department of Obstetrics & Gynaecology, Zwolle, Netherlands

  5. 5

    Leiden University Medical Center, Department of Immunohaematology and Blood Transfusion, Leiden, Netherlands

*Ninke Leffers, Obstetrics & Gynecology CB30, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30.001, Groningen, 9700 RB, Netherlands. n.leffers@og.umcg.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

This is not the most recent version of the article. View current version (17 SEP 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lana E Kandalaft, Cheryl L Chiang, Janos Tanyi, Greg Motz, Klara Balint, Rosemarie Mick, George Coukos, A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer, Journal of Translational Medicine, 2013, 11, 1, 149

    CrossRef

  2. 2
    Vincent Lavoué, Aurélie Thédrez, Jean Levêque, Fabrice Foucher, Sébastien Henno, Vincent Jauffret, Marc-Antoine Belaud-Rotureau, Veronique Catros, Florian Cabillic, Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer, Journal of Translational Medicine, 2013, 11, 1, 147

    CrossRef

  3. 3
    Alexandra Snyder, Jaron E. Tepper, Susan F. Slovin, Perspectives on Immunotherapy in Prostate Cancer and Solid Tumors: Where Is the Future?, Seminars in Oncology, 2013, 40, 3, 347

    CrossRef

  4. 4
    Ninke Leffers, Toos Daemen, Wijnand Helfrich, H Marike Boezen, Ben J Cohlen, Cornelis JM Melief, Hans W Nijman, Antigen-specific active immunotherapy for ovarian cancer, The Cochrane Library,
  5. 5
    Britta K Stordal, Dónal P O'Mathúna, Taxane monotherapy for the treatment of platinum pre-treated epithelial ovarian cancer, The Cochrane Library,